Mizuho’s Jared Holz details potential biotech, pharma acquisitions

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

Mizuho’s Jared Holz joins the ‘Fast Money’ team to discuss the potential impact of expiring patents within the biotech and pharmaceuticals industries.